02.12.2015 • NewsElaine BurridgeEngineeringGenomatica

Genomatica and Braskem Find Direct Route to Bio-butadiene

Bioengineering company Genomatica and Brazilian petrochemical producer Braskem have successfully produced butadiene (BD) at laboratory scale using their direct, bio-based process.

A joint team has developed a microorganism that consumes sugar and converts it to BD, using two-liter fermenters. The companies had previously selected five potential biological pathways from 60 candidates that Genomatica had identified using computational tools.

Nelson Barton, Genomatica’s senior vice president R&D, said the team has quickly hit a key milestone and its rational approach to strain design should enable faster, more predictable scale-up and better economics as the program advances.

The additional intellectual property gained will support subsequent development stages and represents an important competitive advantage, the companies said.

Braskem has been producing 200,000 t/y of polyethylene from ethanol since 2010 and has another cooperation underway to develop bio-based isoprene.

Genomatica is also developing a bioprocess for polyamide intermediates with Italy’s Versalis.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read